The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

Fri, 01st Dec 2023 07:41

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

According to Nationwide, the annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis.

"There has been a significant change in market expectations for the future path of bank rate in recent months which, if sustained, could provide much needed support for housing market activity," said Robert Gardner, Nationwide's chief economist.

So far on Friday morning, there have been manufacturing purchasing managers' index readings from China, Ireland and Japan. The economic calendar still has a slew of manufacturing PMI releases, including for the EU, Germany, the UK and the US.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.3% at 7,478.50

----------

Hang Seng: down 1.0% at 16,869.78

Nikkei 225: closed down 0.2% at 33,431.51

S&P/ASX 200: closed down 0.2% at 7,073.20

----------

DJIA: closed up 520.47 points, 1.5%, at 35,950.89

S&P 500: closed up 17.22 points, or 0.4%, at 4,567.80

Nasdaq Composite: closed down 32.27 points, or 0.2%, at 14,226.22

----------

EUR: up at USD1.0911 (USD1.0909)

GBP: down at USD1.2638 (USD1.2652)

USD: up at JPY148.22 (JPY147.85)

Gold: up at USD2,040.60 per ounce (USD2,038.85)

(Brent): up at USD80.61 a barrel (USD80.56)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

08:30 EST Canada labour force survey

09:30 EST Canada manufacturing PMI

10:00 CET EU manufacturing PMI

09:50 CET France manufacturing PMI

09:55 CET Germany manufacturing PMI

09:15 CET Spain manufacturing PMI

09:30 GMT UK manufacturing PMI

09:00 EST US Fed Chicago President Austan Goolsbee speaks

09:45 EST US S&P Global manufacturing PMI

10:00 EST US ISM manufacturing PMI

----------

The annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis, according to new data from Nationwide. On a seasonally adjusted basis, UK house prices rose by 0.2% in November from October, with growth slowing slightly from a 0.9% on-month rise in October. On an annual basis, prices were 2.0% lower in November, slowing from the 3.3% fall in October. The average house price, without seasonal adjustment, was GBP258,557 in November, down from GBP259,423 in October.

----------

A rise in new orders pushed China's factory sector back into growth in November, survey results from S&P Global showed. The Caixin manufacturing purchasing managers' index rose to a three-month high of 50.7 points last month from 49.5 in October. The reading above 50 points indicates growth in the sector. The Caixin PMI moved in the opposite direction from the same indicator issued by the National Bureau of Statistics on Thursday. Its manufacturing PMI reading for November was 49.4 points, still in contraction territory and slightly down from 49.5 in October. "Demand continued to grow, as the gauge for new orders remained in expansionary territory for the fourth consecutive month, hitting the highest since June," said Wang Zhe, senior economist at Caixin Insight Group. "Compared with consumer goods and intermediate goods, the supply and demand of investment goods were weaker.

----------

Manufacturing conditions in Japan continued to worsen in November, but performed better than initially indicated. The au Jibun manufacturing PMI fell to 48.3 points in November from 48.7 in October, but outperformed the flash estimate, and FXStreet-cited consensus, which were both at 48.1. Edging away from the 50 point mark separating expansion from contraction, the reading indicates an accelerated contraction in activity.

----------

A two-month decline in factory sector activity in Ireland was arrested in November, though only just barely, amid an improvement in production requirements, according to survey results released by S&P Global. Less positively, export orders declined for the third straight month. The AIB Ireland manufacturing PMI came in at 50.0 points in November, indicating neither growth nor decline. This was up from 48.2 points in October and 49.6 in September and was the second highest reading since February.

----------

BROKER RATING CHANGES

----------

UBS raises Antofagasta to 'buy' (neutral) - price target 1,700 (1,600) pence

----------

UBS raises Anglo American to 'buy' (neutral) - price target 2,500 pence

----------

Deutsche Bank cuts Pearson to 'hold' (buy) - price target 1,050 (1,100) pence

----------

COMPANIES - FTSE 100

----------

AstraZeneca has decided to discontinue the Stabilize-ckd and Dialize-Outcomes Phase III evidence trials for Lokelma, sodium zirconium cyclosilicate. The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice. They are part of the Crystalize evidence programme, which researches the benefit of Lokelma in the management of hyperkalaemia across the cardiorenal spectrum.

----------

COMPANIES - FTSE 250

----------

3i Infrastructure said it has completed the sale of its 25% stake in Attero, a waste treatment and recycling companies in the Netherlands. The sale, to Ardian, was announced back in July. 3i will receive EUR215 million for the sale, which will be used to partially repay drawings on the company's revolving credit facility. Also, 3i said it has completed a further investment of GBP30 million in Future Biogas to fund the acquisition of two anaerobic digestion plants which are currently operated by Future Biogas.

----------

OTHER COMPANIES

----------

James Halstead updated shareholders ahead of its annual general meeting Friday. It said that whilst its "major markets face strong competition", it is seeing improved output and profits which are materially ahead of the comparatives. "We are confident of achieving full year market expectations of improved bottom line results and exceeding the half year comparatives, as well as extending our track record of increased dividends," Chair Anthony Wild said. "I and the board remain positive about the medium-term prospects for the group as a whole."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.